Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB

The endocannabinoid enzyme, fatty acid amide hydrolase (FAAH), has been proposed as a therapeutic target for alcohol use disorder (AUD) and co-morbid psychiatric illnesses. Investigating this target in the living human brain and its relationship to clinical outcome is a critical step of informed dru...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychopharmacology
Main Authors: Best, Laura M., Williams, Belinda, Le Foll, Bernard, Mansouri, Esmaeil, Bazinet, Richard P., Lin, Lin, De Luca, Vincenzo, Lagzdins, Dina, Rusjan, Pablo, Tyndale, Rachel F., Wilson, Alan A., Hendershot, Christian S., Heilig, Markus, Houle, Sylvain, Tong, Junchao, Kish, Stephen J., Boileau, Isabelle
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298050/
https://ncbi.nlm.nih.gov/pubmed/31910433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0606-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items